PMID- 14726223 OWN - NLM STAT- MEDLINE DCOM- 20040928 LR - 20190922 IS - 1043-6618 (Print) IS - 1043-6618 (Linking) VI - 49 IP - 3 DP - 2004 Mar TI - Inhibitory effect of polypeptide from Chlamys farreri on ultraviolet A-induced oxidative damage on human skin fibroblasts in vitro. PG - 265-74 AB - We have previously reported that polypeptide from Chlamys farreri (PCF) inhibits the oxidative damage of ultraviolet A (UVA) on HeLa cells in vitro [Acta Pharm. Sin. 23 (2002) 961]. To further elucidate a possible role for PCF on UVA-damaged normal human cells, we established the oxidative damage models of normal human dermal fibroblasts (NHDF) exposed to UVA to study the protective effect of PCF on human dermal fibroblasts in vitro. In this study, 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) method was used to detect the cell viability. The intracellular superoxide dismutase (SOD), glutathione peroxidase (GSH-px), catalase (CAT), xanthine oxidase (XOD), malondialdehyde (MDA), reactive oxygen species (ROS), total antioxidative capacity (T-AOC), and anti-superoxide anion capacity (A-ASC) were measured. The effect of PCF on UVA-induced apoptosis were investigated by Annexin V-FITC assay. Intracellular calcium was determined with the calcium-sensitive fluorochrome Fluo-3, and mitochondrial transmembrane potential with rhodamine 123. Comet assay was employed to detect the UVA-induced DNA damage. The ultrastructure of cell was observed under transmission electron microscope. The results indicated that PCF could greatly enhance the viability of NHDF and markedly promote SOD, GSH-px, T-AOC, and A-ASC, while the amounts of MDA and ROS, the activity of XOD were decreased. PCF could inhibit UVA-induced apoptosis and DNA damage in NHDF. The concentration of cellular free calcium was decreased and the mitochondrial transmembrane potential was increased by PCF. In ultrastructure of NHDF, PCF could greatly decrease UVA-induced damage, especially membrane. Our results suggest that the supplementation of PCF appears to reduce the UVA-induced normal human dermal fibroblasts damage efficiently. It may be involved in the PCF's abilities of scavenging oxygen free radical, inhibiting lipid peroxidation, increasing antioxidative enzymes, decreasing intracellular calcium and protection of membrane structure in NHDF irradiated by UVA. FAU - Han, Yan-Tao AU - Han YT AD - Medical College, Qingdao University, Qingdao, Shandong, 266021, China. FAU - Han, Zhi-Wu AU - Han ZW FAU - Yu, Guo-Ying AU - Yu GY FAU - Wang, Yue-Jun AU - Wang YJ FAU - Cui, Rui-Yao AU - Cui RY FAU - Wang, Chun-Bo AU - Wang CB LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Netherlands TA - Pharmacol Res JT - Pharmacological research JID - 8907422 RN - 0 (Peptides) SB - IM MH - Animals MH - Apoptosis/drug effects/physiology MH - Cell Survival/drug effects/physiology/radiation effects MH - Cells, Cultured MH - Fibroblasts/drug effects/physiology/*radiation effects MH - Humans MH - Male MH - Mollusca MH - Oxidative Stress/physiology/*radiation effects MH - Peptides/*pharmacology MH - Shellfish MH - Skin/drug effects/*radiation effects MH - Ultraviolet Rays/*adverse effects EDAT- 2004/01/17 05:00 MHDA- 2004/09/29 05:00 CRDT- 2004/01/17 05:00 PHST- 2004/01/17 05:00 [pubmed] PHST- 2004/09/29 05:00 [medline] PHST- 2004/01/17 05:00 [entrez] AID - S1043661803003098 [pii] AID - 10.1016/j.phrs.2003.09.009 [doi] PST - ppublish SO - Pharmacol Res. 2004 Mar;49(3):265-74. doi: 10.1016/j.phrs.2003.09.009.